**Abbreviations:** ALT, alanine aminotransferase; AST, aspartate aminotransferase; CT, computed tomography; GBWR, graft-body weight ratio; INR, international normalized ratio; LDLT, living donor liver transplantation; LLS, left lateral segment; LT, liver transplantation; MELD, model for end-stage liver disease; γGT, gamma-glutamyl-transpeptidase.

Introduction {#j_iss-2017-0047_s_001}
============

Liver transplantation (LT) has become an established treatment for children with end-stage liver disease. Among the group of very small liver recipients, the most frequent disease leading to LT is biliary atresia, followed by several other chronic liver diseases \[[@j_iss-2017-0047_ref_001]\], \[[@j_iss-2017-0047_ref_002]\]. This special group of patients often requires transplantation before reaching a body weight of 10 kg. Therefore, performing LT in these patients remains a surgical challenge due to vascular complications, hypercoagulation, and, most important, size mismatching. Precise surgical planning including preoperative hepatic volumetry is required to avoid large-for-size grafts resulting in increased intra-abdominal pressure.

In addition, the organ supply from a deceased donor for infant recipients is much smaller than the actual demand, which makes it difficult to find adequate organs matching the small size of these patients and tightens the major problem of massive organ shortage in LT \[[@j_iss-2017-0047_ref_001]\]. Besides new approaches like using ABO-incompatible or split grafts \[[@j_iss-2017-0047_ref_003]\], \[[@j_iss-2017-0047_ref_004]\], the most important possibility to overcome the organ shortage for infants and to avoid mortality while on the waiting list remains living donor LT (LDLT). In order to receive grafts that better match the size of small recipients, Kitajima et al. \[[@j_iss-2017-0047_ref_005]\] recently reported on LDLT using reduced-thickness left lateral segment (LLS) grafts.

In order to assess the expected graft size, computed tomography (CT)-based volumetry of the donor liver has become an established examination prior to LDLT. Thus far, there are no reports investigating the clinical impact of the results of CT liver volumetry before LDLT in small-sized infants. As it is important to know aspects of volumetry that actually influence the course and the outcome of LDLT, in the present study, we investigated which parameters of pretransplant liver volumetry affect the outcome in extremely small recipients. The primary endpoint of our study was the outcome after LDLT; the secondary endpoints were identifying risk factors that influence the outcome after LDLT.

Materials and methods {#j_iss-2017-0047_s_002}
=====================

The study design was reviewed and approved by the Local Research Ethical Committee (no. 17-7412-BO). In this study, we included all paediatric patients with a body weight ≤10 kg undergoing LDLT between January 2004 and December 2014 at one university transplant centre. The medical records of all recipients and donors were analysed retrospectively. Two patients were excluded from the study: one patient died during the operation, whereas another patient needed to be left anhepatic after the first LT and received a second LT on the same day.

The primary endpoint was the outcome, characterised by patient and graft survival. We focussed on those patients who received LDLT and evaluated the postoperative clinical course by identifying risk factors leading to a poorer outcome.

CT liver volumetry {#j_iss-2017-0047_s_002_s_001}
------------------

In cases, the preoperative CT scans of the donor were evaluated and the diameter of segment II/III was assessed in all three dimensions: ventro-dorsal (thickness), cranio-caudal (length), and transversal (width) ([Figure 1](#j_iss-2017-0047_fig_001){ref-type="fig"}). The total liver volume was calculated after boundaries of the hepatic lobe were drawn manually on consecutive 5-mm-thick axial portal-venous phase CT images (no gap). Volumes were calculated by multiplying the slice thickness with the sum of all traced areas of the respective hepatic lobe. Manual measurement was favoured over automatic measurements, as automatic programs identify the left hepatic vein as the boundary whereas transplant surgeons choose their resection plane slightly moving into segment IV, so that automatic measurements would deliver too small values for the estimated graft volume.

![CT of the liver.\
Axial portal-venous phase CT image with the ventro-dorsal diameter of a female donor liver.](iss-3-20170047-g001){#j_iss-2017-0047_fig_001}

Correlations between one-dimensional measurements and volumes were analysed.

Surgical technique {#j_iss-2017-0047_s_002_s_002}
------------------

The surgical technique for the donor and recipient operation followed previously described principles \[[@j_iss-2017-0047_ref_001]\], \[[@j_iss-2017-0047_ref_006]\], \[[@j_iss-2017-0047_ref_007]\], \[[@j_iss-2017-0047_ref_008]\]. All LTs were carried out via an open transverse laparotomy. The graft was anastomosed to the recipients' inferior vena cava by using the piggy-back technique. Anastomoses of the portal vein and hepatic artery were performed by using the end-to-end technique. The bile flow was maintained by performing a bileo-enteric anastomosis. Immediately after vascular anastomosis, intraoperative duplex ultrasound was performed, and portal venous, hepatic artery, and venous outflow were measured.

Primary abdominal closure was performed when the muscular abdominal wall could be well adapted. If, however, the portal venous or arterial flow was impaired upon approximation and the portal venous flow was \<10 mL/min, the abdomen was left open and a silicon foil was inserted, as described before \[[@j_iss-2017-0047_ref_009]\]. Therefore, duplex ultrasound was repeatedly performed before and after abdominal wall closure. The decision for temporary abdominal closure was also made according to the surgeons' evaluation in case of limited intra-abdominal space when the muscular abdominal wall could not be adapted after the surgery. Heparin (50 IE/kg) was administered postoperatively for a minimum of 7 days in uncomplicated cases and then replaced by acetylsalicylic acid (50 mg 3×/week).

Statistical analysis {#j_iss-2017-0047_s_002_s_003}
--------------------

Statistical analysis was performed using Fisher's exact test and unpaired Student's t-test with significance assumed at p\<0.05. The correlation between two variables was determined by calculating the Pearson product-moment correlation coefficient. Laboratory data of donors and recipients as well as demographic data are given as mean and range.

Results {#j_iss-2017-0047_s_003}
=======

LDLT: recipient and donor characteristics {#j_iss-2017-0047_s_003_s_001}
-----------------------------------------

In the study period, 48 infants with a body weight of ≤10 kg \[20 male (42%), 28 female (58%)\] underwent LDLT in a single university transplant centre. The mean body weight of the 48 paediatric recipients was 7.3 kg (range 4.4--10 kg). The underlying diseases for the LDLT were extrahepatic biliary atresia in 38 cases; hepatoblastoma in three cases; progressive familial intrahepatic cholestasis type 2 in two cases; primary hyperoxaluria in two cases; and Alagille syndrome, toxic liver failure, and cholestatic liver disease of unknown origin in one case each. These patients spent a mean time of 40 days (range 1--345 days) on the waiting list for LT. The mean model for end-stage liver disease score was 15 (range 6--35), and the mean paediatric end-stage liver disease score was 28 (range 22--40). In three cases (6.3%), an ABO-incompatible LDLT was performed.

One donor for LDLT was the grandmother, whereas all other donors were parents of the recipients \[fathers 16 (33%), mothers 31 (65%)\], with one mother being an unrelated adoptive mother. The mean age of the donors was 31.8 years (range 22.1--48.3 years), and their mean body mass index was 24.4 (range 18--33.4). The mean graft-body weight ratio (GBWR) was 4.38% (range 1.41--8.04%). The mean donor weight-graft weight ratio was 9.9 (range 5.2--15.3).

LDLT: CT volumetry {#j_iss-2017-0047_s_003_s_002}
------------------

In all cases, a CT-based volumetry of the donor liver was performed prior to LDLT. The mean estimated total liver volume of the donor was 1579 cm^3^ (range 865--3060 cm^3^). As we regularly use the LLS for LDLT, in all cases, liver segment II/III of the donor was measured to estimate the graft volume and diameters. The mean ventro-dorsal diameter of segment II/III was 6.9 cm (range 4.3--11.2 cm); the mean cranio-caudal diameter was 9 cm (range 5--14 cm). The mean transversal diameter, describing the width of the graft, was 10.5 cm (range 6--14.7 cm). The grafts from male donors had a significantly larger thickness (ventro-dorsal diameter, p\<0.005) than those from female donors.

The mean estimated graft volume was 255 mL (range 140--485 mL). There was no difference between male and female donors concerning the estimated graft weight. The actual measured mean graft weight at transplantation was 307 g (range 127--463 g). There was no significant difference between the estimated graft volume and the actual measured graft weight. However, the ratio describing the accuracy of the estimated graft volume by CT volumetry (mean estimated graft volume/actual graft weight) was 85% (range 48--168%), indicating that CT volumetry estimated a graft volume that was lower than the actual measured graft weight.

By analysing correlations between one-dimensional measurement, we found the following formulas for estimating the graft volume:

-   Male donors: graft volume (mL)=83.1+2.2 ∗ ventro-dorsal diameter (deviation±23% (10/90-quantile: −22.8%/18.1%)

-   Female donors: graft volume (mL)=116.76+0.23 ∗ cranio-caudal diameter ∗ ventro-dorsal diameter \[deviation±50/61% (10/90-quantile: −39%/26%\].

A formula for the accurate estimation of the graft volume including all three dimensions of segment II/III (ventro-dorsal, cranio-caudal, and transversal) could not be identified.

LDLT: outcome {#j_iss-2017-0047_s_003_s_003}
-------------

The mean operation duration for LDLT was 426 min (range 281--1273 min). The mean cold ischaemic time was 92 min (range 6--298 min), whereas the mean warm ischemic time was 45 min (range 15--123 min). After LDLT, 33 recipients (69%) received primary abdominal closure and 15 (31%) received temporary abdominal closure. The serum activities of liver enzymes, bilirubin, and coagulation parameters before and 6 months after transplantation are shown in [Table 1](#j_iss-2017-0047_tab_001){ref-type="table"}. Surgical complications included pleural effusion (n=21), hepatic artery thrombosis (n=12), portal vein thrombosis (n=9), biliary leakage (n=7), chylascites (n=7), biliary stenosis (n=6), intra-abdominal bleeding (n=5), and gastrointestinal bleeding (n=4). After LDLT, the patient and graft survival rates were 85% and 81%, respectively.

###### 

Serum levels of different liver markers preoperatively and 6 months after LT.

                              Mean (range)        
  --------------------------- ------------------- -------------------
  Bilirubin (mg/dL)                               
   Whole cohort               12.4 (0.1--44)      2.1 (0.1--34.3)
   LDLT                       14 (0.2--44)        1.4 (0.1--21.1)
  Prothrombin time (quick%)                       
   Whole cohort               61 (10--120)        83 (26--114)
   LDLT                       64 (16--120)        85 (28--114)
  PTT (s)                                         
   Whole cohort               55 (21--170)        38 (21--160)
   LDLT                       56 (23--160)        40 (21--160)
  INR                                             
   Whole cohort               1.57 (0.86--4.78)   1.07 (0.95--1.33)
   LDLT                       1.45 (0.86--3.81)   1.06 (0.95--1.33)
  γGT (U/L)                                       
   Whole cohort               171 (10--1829)      113 (4--2207)
   LDLT                       162 (10--1829)      102 (7--2207)
  ALT (U/L)                                       
   Whole cohort               290 (15--4946)      185 (9--2894)
   LDLT                       166 (23--1874)      143 (13--2109)
  AST (U/L)                                       
   Whole cohort               475 (26--8197)      529 (20--14253)
   LDLT                       230 (26--811)       239 (20--5132)

LT, Liver transplantation; LDLT, living donor liver transplantation; PTT, partial thromboplastin time; INR, international normalised ratio; γGT, gamma-glutamyl-transpeptidase; ALT, alanine aminotransferase; AST, aspartate aminotransferase.

Overall, there were five cases of graft loss secondary to vascular complications. The graft loss was caused by hepatic arterial thrombosis in four cases and by hepatic vein thrombosis in one case. In two of these five cases, there was a large-for-size situation with a GBWR \>4%. The other three cases had a GBWR \<4%, and none had a GBWR \>6%.

LDLT: risk factors {#j_iss-2017-0047_s_003_s_004}
------------------

In statistical analysis, we identified several clinical and biochemical parameters as risk factors for a poorer patient or graft survival in the group who received LDLT ([Table 2](#j_iss-2017-0047_tab_002){ref-type="table"}). The characteristics of the graft affecting patient survival were a high graft weight, a GBWR of \>4%, and a large ventro-dorsal diameter of segment II/III (graft thickness), measured using CT volumetry ([Figure 2](#j_iss-2017-0047_fig_002){ref-type="fig"}). A GBWR of \>4% affected both patient survival and graft survival. There was no correlation between any other parameter concerning the donor liver measured in CT volumetry and the outcome. However, the occurrence of vascular thrombosis, including hepatic artery and portal vein thrombosis, was identified in multivariable analysis as an independent risk factor for both poorer patient survival and graft survival. There was no correlation between the occurrence of thrombosis and any of the estimated graft diameters.

###### 

Risk factors for poorer patient and graft survival (univariate analysis).

  Risk factor                     Patient survival (p-value)   Graft survival (p-value)
  ------------------------------- ---------------------------- --------------------------
  Vascular thrombosis             Yes (0.007)^a^               Yes (0.017)^a^
  MELD                            Yes (0.05)^a^                --
  Graft weight                    Yes (0.006)^a^               --
  GBWR \>4%                       Yes (0.03)                   Yes (0.04)^a^
  Recipient age at LT             Yes (0.08)                   --
  Donor age                       --                           Yes (0.04)
  AP diameter of segment II/III   Yes (0.045)                  --
  Temporary abdominal closure     Yes (0.04)                   --
  Days at waiting list            Yes (0.05)                   Yes (0.06)

MELD, Model for end-stage liver disease; GBWR, graft-body weight ratio; LT, liver transplantation; AP, anteroposterior. ^a^Independent risk factor (multivariable analysis).

![Boxplot showing the correlation between graft thickness and graft survival.\
Left box: Patients with graft loss (n=9). Graft loss median graft thickness: 103 mm. Graft loss 25 quartile: 98 mm. Graft loss 75 quartile: 113 mm. Right box: Patients with graft survival (n=39). Graft survival median graft thickness: 99 mm. Graft survival 25 quartile: 87 mm. Graft survival 75 quartile: 122 mm.](iss-3-20170047-g002){#j_iss-2017-0047_fig_002}

Discussion {#j_iss-2017-0047_s_004}
==========

Preoperative imaging of the liver donor with estimation of the graft size has become a crucial investigation prior to LT. According to Lim et al. \[[@j_iss-2017-0047_ref_010]\], imaging-based volumetry of the liver is vital in the preoperative planning for LT, as the liver volume is one key factor in the selection of the appropriate individual for LDLT. Especially in LDLT, precise assessment of the donor liver volume is crucial in determining whether the donor is suitable for LDLT, to ensure safety for both donor and recipient \[[@j_iss-2017-0047_ref_010]\]. In addition, preoperative imaging is required to ensure that there is no underlying focal or diffuse liver disease that may make transplantation unsuitable, such as steatosis, cirrhosis, and focal benign or malignant neoplasms.

Currently, the preferred means of imaging-based liver and graft size estimation is CT volumetry, which generally provides good correlation of the estimated volume with the graft weight obtained \[[@j_iss-2017-0047_ref_010]\], \[[@j_iss-2017-0047_ref_011]\]. Yoon et al. \[[@j_iss-2017-0047_ref_012]\] used the actual graft weight as a standard of reference in living liver donors for determination of the accuracy, reproducibility, and improvement in the clinical workflow of a semi-automatic CT virtual surgical planning program in estimating graft volume. The authors reviewed the liver CTs of 105 liver donor candidates, and found a strong correlation between the predicted volumes of the hepatic graft and the actual graft weight. Furthermore, the mean processing time of hepatic volumetry, segmentation, and surgical planning using software was significantly shorter than using manual volumetry.

An actual clinical impact of preoperative imaging before LDLT was first described by Ringe et al. \[[@j_iss-2017-0047_ref_013]\]. In a study on the significance of CT in the donor selection process, the authors found that almost one-third of the donor candidates were rejected because of CT findings. The authors concluded that CT can help reduce the risk for donors and recipients by excluding unsuitable donor livers.

However, these studies did not exclusively address liver donors for infants. One critical challenge in extremely small-sized infants receiving LDLT is the increased risk for developing large-for-size syndrome. In the past, several authors described different approaches, trying to avoid a large-for-size situation in small-sized liver recipients: Ogawa et al. \[[@j_iss-2017-0047_ref_014]\] used reduced monosegmental grafts for LDLT in nine extremely small-sized infants, and reported a patient and graft survival at 1 year of 66.7%. They concluded that reduced monosegmental LDLT represents a feasible option for neonates and extremely small infants with liver failure.

Another approach to avoid a large-for-size situation was recently published by Yamada et al. \[[@j_iss-2017-0047_ref_015]\]. The group reported on their graft selection strategy being based on preoperative CT volumetry for recipients ≤6 kg. The group's strategy for graft selection among those patients depended on the GBWR, based on the donor preoperative CT volumetry for the LLS graft. When the predictive GBWR of the LLS graft was ≤5%, they selected the LLS as the liver graft. When the predictive GRWR of the LLS graft was \>5%, they selected the S2 monosegment as the liver graft. When the actual GRWR was \>4%, they performed partial graft hepatectomy *ex vivo* to reduce the GRWR to ≤4%. The authors concluded that their graft selection strategy based on the preoperative CT volumetry value is highly useful in patients weighing ≤6 kg. They stated that the use of S2 monosegment grafts is effective and safe in very small infants and particularly in neonates. Recently, Kitajima et al. \[[@j_iss-2017-0047_ref_005]\] reported on their experience with reducing the thickness of the LLS and stated that LDLT using reduced LLS is a feasible option with better outcomes when compared with non-reduced grafts.

In contrast to these studies, the study by Schulze et al. \[[@j_iss-2017-0047_ref_003]\] showed that using exclusively left lateral grafts from living donors or split grafts for extremely small paediatric liver recipients leads to an excellent outcome without the need for reduction of the grafts or the use of monosegments. The group used temporary abdominal closure in a high proportion of their patients, in 28% of the whole cohort and in 39% of the large-for-size group, and stated that the use of a patch is one possibility to avoid large-for-size syndrome. However, recently, our group found that LDLT is possible without reduction and without the necessity of a patch in some cases of a high GBWR \[[@j_iss-2017-0047_ref_009]\]. According to this strategy, our group performed all LDLTs using the LLS without any form of a further graft reduction.

Another key factor in avoiding a large-for-size situation in extremely small-sized liver recipients is CT-based graft size estimation, which is a precise estimation of the graft size. Thus far, there have been no reports on the outcome after LDLT depending on the results of preoperative CT liver volumetry. As this investigation has become a standard procedure, it is important to know which aspects of volumetry actually have clinical relevance, and whether they influence the course and the outcome after LDLT.

In the present study, we provide, for the first time, different diameters of the estimated graft size for recipients ≤10 kg, combining them with clinical data and their impact on the outcome. We found that not only the graft weight but also the estimated thickness of the graft, characterised by the ventro-dorsal diameter of segment II/III, significantly influenced patient survival, whereas the total volume of the donor liver and the volume of the graft had no influence. This goes along with the findings of Schulze et al., who noted that the ventro-dorsal diameter of the graft appeared to be more relevant to potential graft necrosis than the actual graft size \[[@j_iss-2017-0047_ref_003]\]. One possible explanation could be the mismatch between the vessels of the graft and the small-sized ones of the neonatal recipient. The difference in the vessel size might rather be a limiting factor in the transplantation procedure than the actual volume of the graft. This clinically relevant aspect in preoperative CT liver volumetry is new and might be beneficial in finding the appropriate graft for extremely small-sized recipients. However, the present study has limitations. We did not differentiate between biliary atresia patients who often show hypoplastic portal veins and cirrhotic livers and therefore might require different surgical strategies as opposed to patients with non-cirrhotic liver diseases. Also, donor-associated factors such as comorbidities or alcohol consumption could have influenced the outcome. The study is also limited by its retrospective nature, and a further prospective study is needed to verify our results. Should the influence of the segment II/III ventro-dorsal diameter on the outcome be confirmed, possibly a cut-off diameter of segment II/III of the donor liver could be recommended before LDLT in extremely small-sized infants to reduce the risk of large-for-size syndrome. However, it is important to note that graft function and survival are not only influenced by graft size but are also affected by other factors. In our present study, the number of days the recipients spent on the waiting list for transplantation, a GBWR \>4%, and the occurrence of vascular thrombosis were risk factors for both poorer patient and graft survival, which agrees with the results of previously published studies on parameters affecting the outcome after LT \[[@j_iss-2017-0047_ref_016]\], \[[@j_iss-2017-0047_ref_017]\], \[[@j_iss-2017-0047_ref_018]\].

Conclusion {#j_iss-2017-0047_s_005}
==========

Preoperative assessment of the graft size is a crucial investigation before LDLT. We identified larger graft thickness, estimated by measuring the ventro-dorsal diameter of segment II/III in CT donor liver volumetry, as a risk factor for a poorer patient survival. This new aspect might be helpful in finding more grafts for extremely small-sized recipients despite high donor volumes of segment II/III when its configuration is slim.
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